Steven Charles Nelson bought $8,244 of DRIO
Chief Commercial Officer at DarioHealth Corp.. 10,000 shares at an average of $0.82, traded Sep 10, 2024, filed Sep 12, 2024.
Score components
- +15RoleOfficer
- 0Trade size$8k at market
- +6Relative to holdingsHoldings up 25%
- +18Price context1% above the 52-week low; 77% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying4 buys in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +22.9%, 3m -9.6%, 6m -21.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-099353, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | POpen-market purchase Common Stock | +5,000 | $0.84 | $4,221 | 45,000 | Sep 12, 2024 |
| Sep 11, 2024 | POpen-market purchase Common Stock | +5,000 | $0.80 | $4,023 | 50,000 | Sep 12, 2024 |
Related signals
Other insiders at DarioHealth Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | DRIObuy DarioHealth Corp. | Dennis Matheis director | $100k 14,430 shares | +50% | |
| 38Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson President and CCO | $21k 40,000 shares | +73% | |
| 18Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $4,546 5,000 shares | +10% | |
| 56Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $12k 15,000 shares | +60% | |
| 51Moderate | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $4,400 5,000 shares | +0% | |
| 41Moderate | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $9,400 10,000 shares | +1% | |
| 46Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $14k 15,000 shares | +150% | |
| 36Weak | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $8,980 10,000 shares | +1% | |
| 39Weak | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $9,283 10,000 shares | - | |
| 6Weak | DarioHealth Corp. | Dennis M McGrath director | $39k 9,872 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.